©Shutterstock/David Smart
New preclinical NIDA-funded research shows that a new compound, BU08028, acts on opioid and non-opioid brain receptors to relieve pain without harmful side effects. In the study, primates experienced pain relief but did not become dependent upon BU08028, and in fact,...
↧